BlackRock Investment Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

BlackRock Investment Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.13M	Buy	8,296 +33	+0.4%	+$5.86K	﹤0.01%	2624
2016 Q3	$1.64M	Sell	8,263 -14	-0.2%	-$2.41K	﹤0.01%	2314
2016 Q2	$1.07M	Buy	8,277 +5,296	+178%	+$589K	﹤0.01%	2572
2016 Q1	$279K	Buy	2,981 +52	+2%	+$5.66K	﹤0.01%	3094
2015 Q4	$594K	Buy	2,929 +56	+2%	+$10K	﹤0.01%	2931
2015 Q3	$417K	Sell	2,873 -142	-5%	-$26.1K	﹤0.01%	3091
2015 Q2	$641K	Buy	3,015 +526	+21%	+$129K	﹤0.01%	3040
2015 Q1	$577K	Buy	+2,489	New	+$602K	﹤0.01%	2884

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

BlackRock Investment Management's BLCM Position: Q4 2016 in Review

BlackRock Investment Management increased its Bellicum Pharmaceuticals, Inc. (BLCM) stake by 0.4% in Q4 2016, buying an estimated $5.86K and bringing the position to 8,296 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2624.

BlackRock Investment Management first reported a position in BLCM in Q1 2015 and has held it in 8 quarters since. The position peaked at $1.64M in Q3 2016. 80 funds tracked by Wall St. Rank hold BLCM as of Q4 2016.

BlackRock Investment Management held 8,296 shares of Bellicum Pharmaceuticals, Inc. worth $1.13M as of Q4 2016.
BlackRock Investment Management bought 33 Bellicum Pharmaceuticals, Inc. shares in Q4 2016, an estimated $5.86K.
Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2624 holding.
BlackRock Investment Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and has held it in 8 quarters since.
BlackRock Investment Management's Bellicum Pharmaceuticals, Inc. position peaked at $1.64M in Q3 2016.
80 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.